Does Sotorasib need to be taken long-term?

Sotorasib (Sotorasib) is an oral targeted therapy drug. Its specific usage and course of treatment are usually formulated by doctors based on the patient's specific situation and medical history. Sotoracib is designed to target cancers with mutations in the RAS gene, such as pancreatic cancer, colorectal cancer, and lung cancer. Treatment options may vary depending on the patient's condition, individual differences, and clinical response.

In some cases, targeted therapy may need to be continued for a long period of time to maintain effective suppression of cancer cells. The goal of ongoing treatment is to maintain control of abnormal cells and prevent the cancer from coming back or progressing. However, the specific course and treatment plan need to be discussed in detail between patient and doctor and adjusted as the condition evolves.

When using sotoracib or other targeted therapies, patients usually require frequent medical monitoring and evaluation to ensure the efficacy of the drug and to detect potential side effects in a timely manner. Doctors may use information such as the patient's experience, symptoms, and laboratory tests to decide whether adjustments to the treatment plan are needed.

The original drug of sotorasibu has not yet been launched in China, so patients cannot purchase it domestically and need to purchase sotorasibu through overseas channels. The price of the original version of sotorasibu in Hong Kong, China, with the specifications of 120mg*240 tablets, is around 8 million, and the price of the European version of the original drug with the same specifications is around 4 million, which is relatively expensive. The cheaper ones are the generic drugs marketed abroad. For example, the price of generic drugs in Laos and Bangladesh is around two to three thousand yuan. The price is relatively cheap, and the ingredients of foreign generic drugs are basically the same as the original drugs.